Artelo Biosciences Inc (ARTL)
1.42
+0.06
(+4.41%)
USD |
NASDAQ |
May 17, 16:00
1.42
0.00 (0.00%)
After-Hours: 20:00
Artelo Biosciences Enterprise Value: -3.026M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | -3.026M |
| May 16, 2024 | -3.219M |
| May 15, 2024 | -3.348M |
| May 14, 2024 | -3.312M |
| May 13, 2024 | -3.413M |
| May 10, 2024 | -3.284M |
| May 09, 2024 | -3.122M |
| May 08, 2024 | -3.329M |
| May 07, 2024 | -3.445M |
| May 06, 2024 | -3.348M |
| May 03, 2024 | -3.252M |
| May 02, 2024 | -3.155M |
| May 01, 2024 | -3.413M |
| April 30, 2024 | -3.169M |
| April 29, 2024 | -3.316M |
| April 26, 2024 | -3.284M |
| April 25, 2024 | -3.284M |
| April 24, 2024 | -3.278M |
| April 23, 2024 | -3.381M |
| April 22, 2024 | -3.412M |
| April 19, 2024 | -3.365M |
| April 18, 2024 | -3.478M |
| April 17, 2024 | -3.365M |
| April 16, 2024 | -2.929M |
| April 15, 2024 | -2.981M |
| Date | Value |
|---|---|
| April 12, 2024 | -2.687M |
| April 11, 2024 | -2.512M |
| April 10, 2024 | -2.519M |
| April 09, 2024 | -2.509M |
| April 08, 2024 | -2.542M |
| April 05, 2024 | -2.610M |
| April 04, 2024 | -2.667M |
| April 03, 2024 | -2.703M |
| April 02, 2024 | -2.768M |
| April 01, 2024 | -2.689M |
| March 28, 2024 | -5.649M |
| March 27, 2024 | -5.681M |
| March 26, 2024 | -5.778M |
| March 25, 2024 | -5.566M |
| March 22, 2024 | -5.520M |
| March 21, 2024 | -5.642M |
| March 20, 2024 | -5.738M |
| March 19, 2024 | -5.642M |
| March 18, 2024 | -5.738M |
| March 15, 2024 | -5.834M |
| March 14, 2024 | -5.642M |
| March 13, 2024 | -5.738M |
| March 12, 2024 | -5.562M |
| March 11, 2024 | -5.674M |
| March 08, 2024 | -5.658M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-12.63M
Minimum
Nov 21 2022
39.43M
Maximum
Feb 17 2021
0.9288M
Average
1.092M
Median
Apr 06 2020
Enterprise Value Benchmarks
| Johnson & Johnson | 379.58B |
| NovaBay Pharmaceuticals Inc | 5.156M |
| Palatin Technologies Inc | 22.26M |
| iBio Inc | 16.77M |
| Theriva Biologics Inc | -8.901M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.483M |
| Total Expenses (Quarterly) | 2.589M |
| EPS Diluted (Quarterly) | -0.78 |
| Earnings Yield | -222.5% |